Disorders that are suspected of belonging to the field of neural systems, clinical performance is complex and often involves multi-systemic burden. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
The platform can help align national and international experts and teams to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many of the diseases of the nervous system that have previously been difficult to treat have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely schemes according to changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of PML-associated brain biopsies. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.